|
HY-P1821A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N0547-10mg
|
MedChemexpress LLC
|
Nomilin [CAS 1063-77-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N0547-20mg
|
MedChemexpress LLC
|
Nomilin [CAS 1063-77-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-N0547-5mg
|
MedChemexpress LLC
|
Nomilin [CAS 1063-77-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-13057-10mg
|
MedChemexpress LLC
|
O6BTG-octylglucoside [CAS 382607-78-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13057-100mg
|
MedChemexpress LLC
|
O6BTG-octylglucoside [CAS 382607-78-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13057-5mg
|
MedChemexpress LLC
|
O6BTG-octylglucoside [CAS 382607-78-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13057-50mg
|
MedChemexpress LLC
|
O6BTG-octylglucoside [CAS 382607-78-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13057-1mL
|
MedChemexpress LLC
|
O6BTG-octylglucoside [CAS 382607-78-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N12367-5mg
|
MedChemexpress LLC
|
Oroxylin 7-O-glucoside [CAS 36948-77-3]
|
|
|
|
|
HY-112100-10mg
|
MedChemexpress LLC
|
PAC [CAS 2158322-33-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112100-5mg
|
MedChemexpress LLC
|
PAC [CAS 2158322-33-7]
|
|
Cancer-programmed cell death
|
|
|
HY-115627-1mg
|
MedChemexpress LLC
|
PKUMDL-LC-101-D04 [CAS 2143896-83-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-115627-10mg
|
MedChemexpress LLC
|
PKUMDL-LC-101-D04 [CAS 2143896-83-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-115627-25mg
|
MedChemexpress LLC
|
PKUMDL-LC-101-D04 [CAS 2143896-83-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-115627-5mg
|
MedChemexpress LLC
|
PKUMDL-LC-101-D04 [CAS 2143896-83-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-115627-50mg
|
MedChemexpress LLC
|
PKUMDL-LC-101-D04 [CAS 2143896-83-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-112098-10mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112098-2mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112098-25mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112098-5mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112098-50mg
|
MedChemexpress LLC
|
PROTAC ERAlpha Degrader-1 [CAS 2417369-94-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N7766-1mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7766-2mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-N7766-5mg
|
MedChemexpress LLC
|
Rubropunctatin [CAS 514-67-0]
|
|
COVID-19-immunoregulation
|
|
